Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 12/16, from 8 a.m. to 4 p.m. at the Hilton Washington DC North/Gaithersburg, The Ballrooms, 620 Perry Pkwy, Gaithersburg, MD. Contact Nicole Vesely, (301) 827-6793. The committee will discuss Imclone Systems’ BLA for Erbitux (cetuximab) and Amgen, Inc.’s Vectibix (panitumumab), in the context of K-ras as a predictive and/or prognostic biomarker in oncology drug development. To view this notice, click here.